|
⚲
|
| Keyboard |
| Interpace Diagnostics Group Inc
✚
|
|
|---|---|
| CIK # | 0001054102 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001054102] | |
| 10-Q | [0001054102] | |
| 3 | [0001054102] | |
| 4 | [0001054102] | |
| 8-K | [0001054102] | |
| D | [0001054102] | |
| SC 13D | [0001054102] | |
| SC 13G | [0001054102] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Interpace Biosciences Inc IDXG
Series C Convertible Preferred Stock · derivative
|
2026-01-20 | Conversion | 19,000 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2026-01-20 | Conversion | 13,861,386 | $2.02 | 28,000,000 |
|
Interpace Biosciences Inc IDXG
Series C Convertible Preferred Stock · derivative
|
2026-01-20 | Conversion | 28,000 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2026-01-20 | Conversion | 9,405,941 | $2.02 | 19,000,001 |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2024-12-01 | Option exercise | 1,111 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Series B Convertible Preferred Stock · derivative
|
2024-10-11 | Disposed to issuer | 19,000 | ||
|
Interpace Biosciences Inc IDXG
Series C Convertible Preferred Stock · derivative
|
2024-10-11 | Grant | 19,000 | ||
|
Interpace Biosciences Inc IDXG
Series B Convertible Preferred Stock · derivative
|
2024-10-11 | Disposed to issuer | 28,000 | ||
|
Interpace Biosciences Inc IDXG
Series C Convertible Preferred Stock · derivative
|
2024-10-11 | Grant | 28,000 | ||
|
Interpace Biosciences Inc IDXG
Common Stock
|
2024-07-27 | Option exercise | 15,112 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2024-02-01 | Option exercise | 6,045 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2024-02-01 | Grant | 10,000 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2024-01-31 | Option exercise | 7,556 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2023-12-01 | Option exercise | 1,095 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2023-07-31 | Grant | 25,000 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2023-07-31 | Option exercise | 7,556 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Stock Option (right to buy) · derivative
|
2022-02-01 | Grant | 28,000 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Common Stock
|
2021-05-21 | Buy | 10,855 | $8.68 | 94,221 |
|
Interpace Biosciences Inc IDGX
Common Stock
|
2021-03-10 | Grant | 50,000 | ||
|
Interpace Biosciences Inc IDGX
Stock Option (right to buy) · derivative
|
2021-03-10 | Grant | 50,000 | $0.00 | |
| showing 20 of 178 most recent transactions | |||||